Equasens SA 2022 AR2
The report highlights Equasens Group's performance and strategic developments for the fiscal year 2022, including its name change from Pharmagest to Equasens to reflect its diverse healthcare IT solutions. The Group achieved a 10.88% increase in revenue to €214.07 million and an 18.35% rise in net profit to €48.70 million, driven by the French Ségur digital healthcare programme and strategic acquisitions. Equasens expanded its European footprint through acquisitions in Italy, Germany, the UK, and Ireland, while establishing a new Strategy and CSR Committee to oversee its sustainability commitments. Additionally, the Group advanced its Green IT initiatives, successfully reusing or recycling 100% of its offline IT inventory.
Company: Equasens SA
Sector: Health Care
Country: France
Year: 2022
Type: AR2
Pages: 48
Equasens SA
Annual Report
The report highlights Equasens Group's performance and strategic developments for the fiscal year 2022, including its name change from Pharmagest to Equasens to reflect its diverse healthcare IT solutions. The Group achieved a 10.88% increase in revenue to €214.07 million and an 18.35% rise in net profit to €48.70 million, driven by the French Ségur digital healthcare programme and strategic acquisitions. Equasens expanded its European footprint through acquisitions in Italy, Germany, the UK, and Ireland, while establishing a new Strategy and CSR Committee to oversee its sustainability commitments. Additionally, the Group advanced its Green IT initiatives, successfully reusing or recycling 100% of its offline IT inventory.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees